TEST BANK h1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
h1 h1 h1 h1 h1 h1 h1
Author: Teri Moser Woo and Wendy L. Wright
h1 h1 h1 h1 h1 h1 h1
, TABLE OF CONTENT h1 h1
Chapter h1 1. h1 The Role of the Advanced Practice Nurse as Prescriber ............................................................... 4
h1 h1 h1 h1 h1 h1 h1 h1
Chapter h1 2. h1 Review of Basic Principles of Pharmacology ................................................................................. 5
h1 h1 h1 h1 h1
Chapter h1 3. h1 Rational Drug Selection .................................................................................................................. 11
h1 h1
Chapter h1 4. h1 Legal and Professional Issues in Prescribing ................................................................................ 14
h1 h1 h1 h1 h1
Chapter h1 5. h1 Adverse Drug Reactions ................................................................................................................. 16
h1 h1
Chapter h1 6. h1 An Introduction to Pharmacogenomics .......................................................................................... 19
h1 h1 h1
Chapter h1 7. h1 Nutrition and Nutraceuticals ........................................................................................................... 22
h1 h1
Chapter h1 8. h1 Herbal Therapies .............................................................................................................................. 28
h1
Chapter h1 9. Cannabis ........................................................................................................................................... 31
h1
Chapter h1 10. Pharmacoeconomics ....................................................................................................................... 35
h1
Chapter h1 11. Drugs Affecting the Autonomic Nervous System ...................................................................... 38
h1 h1 h1 h1 h1 h1
Chapter h1 12. Drugs Affecting the Central Nervous System ............................................................................. 45
h1 h1 h1 h1 h1 h1
Chapter h1 13. Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
h1 h1 h1 h1 h1 h1 h1
Chapter h1 14. Drugs Affecting the Respiratory System ..................................................................................... 61
h1 h1 h1 h1 h1
Chapter 15. Drugs Affecting the Hematological System ................................................................................ 65
h1 h1 h1 h1 h1 h1
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 17. Drugs Affecting the Immune System: Immunomodulators......................................................... 75
h1 h1 h1 h1 h1 h1 h1
Chapter 18. Drugs Affecting the Gastrointestinal System .............................................................................. 77
h1 h1 h1 h1 h1 h1
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............. 80
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ..................... 83
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 21. Drugs Affecting the Reproductive System .................................................................................. 86
h1 h1 h1 h1 h1 h1
Chapter 22. Drugs Affecting the Bones and Joints ......................................................................................... 92
h1 h1 h1 h1 h1 h1 h1
Chapter 23. Drugs Affecting the Integumentary System ................................................................................ 96
h1 h1 h1 h1 h1 h1
Chapter 24. Drugs Used to Treat Bacterial Infections .................................................................................. 101
h1 h1 h1 h1 h1 h1 h1
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ................................................. 105
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 26. Drugs Used to Treat Inflammatory Processes ........................................................................... 108
h1 h1 h1 h1 h1 h1 h1
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ............................................................................ 111
h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 28. Anemia ......................................................................................................................................... 113
h1 h1
Chapter h1 29. h1 Anxiety and Depression .............................................................................................................. 116
h1 h1
Chapter h1 30. h1 Attention Deficit-Hyperactivity Disorder ................................................................................... 120
h1 h1
Chapter h1 31. h1 Asthma and Allergy .................................................................................................................... 122
h1 h1
Chapter h1 32. h1 Chronic Obstructive Pulmonary Disease .................................................................................... 125
h1 h1 h1
Chapter h1 33. h1 Contraception ............................................................................................................................... 127
Chapter h1 34. h1 COVID-19: Acute and Chronic .................................................................................................. 130
h1 h1 h1
Chapter h1 35. h1 Dermatological Conditions .......................................................................................................... 134
h1
Chapter h1 36. h1 Diabetes Management ................................................................................................................. 138
h1
Chapter h1 37. h1 Gastroesophageal Reflux and Peptic Ulcer Disease.................................................................. 146
h1 h1 h1 h1 h1
Chapter h1 38. h1 Headaches ..................................................................................................................................... 149
Chapter h1 39. h1 Heart Failure ................................................................................................................................ 153
h1
Chapter h1 40. h1 HIV Disease and Acquired Immunodeficiency Syndrome ....................................................... 158
h1 h1 h1 h1 h1
Chapter 41. Menopausal Hormone Therapy................................................................................................... 161
h1 h1 h1 h1
,Chapter 42. Hyperlipidemia ............................................................................................................................. 164
h1 h1
Chapter 43. Hypertension................................................................................................................................. 169
h1 h1
Chapter 44. Hyperthyroidism and Hypothyroidism........................................................................................ 174
h1 h1 h1 h1
Chapter 45. Obesity ......................................................................................................................................... 177
h1 h1
Chapter 46. Pain Management: Acute and Chronic Pain ............................................................................. 181
h1 h1 h1 h1 h1 h1 h1
Chapter 47. Pneumonia .................................................................................................................................... 185
h1 h1
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................ 187
h1 h1 h1 h1 h1 h1
Chapter 49. Substance Use Disorders ............................................................................................................. 190
h1 h1 h1 h1
Chapter 50. Tuberculosis ................................................................................................................................. 195
h1 h1
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ... 197
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 52. Urinary Tract Infections .............................................................................................................. 200
h1 h1 h1 h1
Chapter h1 53. h1 Women as Patients ...................................................................................................................... 203
h1 h1
Chapter h1 54. h1 Men as Patients ........................................................................................................................... 207
h1 h1
Chapter h1 55. h1 Pediatric Patients.......................................................................................................................... 209
h1
Chapter h1 57. h1 Geriatric Patients.......................................................................................................................... 213
h1
, Woo 1
Pharmacotherapeutics for APN Prescribers, h1 h1 h1 Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
MULTIPLE CHOICE h1
1. Nurse practitioner prescriptive authority is regulated by:
h1 h1 h1 h1 h1 h1
A. The National Council of State Boards of Nursing
h1 h1 h1 h1 h1 h1 h1
B. The U.S. Drug Enforcement Administration
h1 h1 h1 h1
C. The State Board of Nursing for each state
h1 h1 h1 h1 h1 h1 h1
D. The State Board of Pharmacy
h1 h1 h1 h1
ANS: h 1 C PTS: h 1 h 1 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
prescriber include:
h1 h1
A. Nurses know more about pharmacology than other prescribers because they take
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
it both in their basic nursing program and in their APRN program.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Nurses care for the patient from a holistic approach and include the
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
patient in decision-making regarding their care.
h1 h1 h1 h1 h1 h1
C. APRNs are less likely to prescribe narcotics and other controlled substances.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
D. APRNs are able to prescribe independently in all states, whereas a
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
physician’s assistant needs to have a physician supervising their practice.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
ANS: h 1 B PTS: h 1 h 1 1
3. Clinical judgment in prescribing includes:
h1 h1 h1 h1
A. Factoring in the cost to the patient of the medication prescribed
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Always prescribing the newest medication available for the disease process
h1 h1 h1 h1 h1 h1 h1 h1 h1
C. Handing out drug samples to poor patients
h1 h1 h1 h1 h1 h1
D. Prescribing all generic medications to cut costs h1 h1 h1 h1 h1 h1
ANS: h 1 A PTS: h 1 h 1 1
4. The process for choosing an effective drug for a disorder includes:
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
A. Asking the patient what drug they think would work best for them
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Consulting nationally recognized guidelines for disease management
h1 h1 h1 h1 h1 h1
C. Prescribing medications that are available as samples before writing a prescription
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
h1 h1 h1 h1 h1 h1 h1
ANS: h 1 B PTS: h 1 h 1 1
5. Nonintentional nonadherence of drug therapy may occur due to:
h1 h1 h1 h1 h1 h1 h1 h1
A. Belief that medication does not work
h1 h1 h1 h1 h1
B. Adverse drug reactions h1 h1
C. Chronic conditions that require daily therapy
h1 h1 h1 h1 h1
D. Forgetfulness or distraction h1 h1
ANS: h 1 D PTS: h 1 h 1 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
h1 h1 h1 h1 h1 h1 h1
Author: Teri Moser Woo and Wendy L. Wright
h1 h1 h1 h1 h1 h1 h1
, TABLE OF CONTENT h1 h1
Chapter h1 1. h1 The Role of the Advanced Practice Nurse as Prescriber ............................................................... 4
h1 h1 h1 h1 h1 h1 h1 h1
Chapter h1 2. h1 Review of Basic Principles of Pharmacology ................................................................................. 5
h1 h1 h1 h1 h1
Chapter h1 3. h1 Rational Drug Selection .................................................................................................................. 11
h1 h1
Chapter h1 4. h1 Legal and Professional Issues in Prescribing ................................................................................ 14
h1 h1 h1 h1 h1
Chapter h1 5. h1 Adverse Drug Reactions ................................................................................................................. 16
h1 h1
Chapter h1 6. h1 An Introduction to Pharmacogenomics .......................................................................................... 19
h1 h1 h1
Chapter h1 7. h1 Nutrition and Nutraceuticals ........................................................................................................... 22
h1 h1
Chapter h1 8. h1 Herbal Therapies .............................................................................................................................. 28
h1
Chapter h1 9. Cannabis ........................................................................................................................................... 31
h1
Chapter h1 10. Pharmacoeconomics ....................................................................................................................... 35
h1
Chapter h1 11. Drugs Affecting the Autonomic Nervous System ...................................................................... 38
h1 h1 h1 h1 h1 h1
Chapter h1 12. Drugs Affecting the Central Nervous System ............................................................................. 45
h1 h1 h1 h1 h1 h1
Chapter h1 13. Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
h1 h1 h1 h1 h1 h1 h1
Chapter h1 14. Drugs Affecting the Respiratory System ..................................................................................... 61
h1 h1 h1 h1 h1
Chapter 15. Drugs Affecting the Hematological System ................................................................................ 65
h1 h1 h1 h1 h1 h1
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 17. Drugs Affecting the Immune System: Immunomodulators......................................................... 75
h1 h1 h1 h1 h1 h1 h1
Chapter 18. Drugs Affecting the Gastrointestinal System .............................................................................. 77
h1 h1 h1 h1 h1 h1
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............. 80
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ..................... 83
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 21. Drugs Affecting the Reproductive System .................................................................................. 86
h1 h1 h1 h1 h1 h1
Chapter 22. Drugs Affecting the Bones and Joints ......................................................................................... 92
h1 h1 h1 h1 h1 h1 h1
Chapter 23. Drugs Affecting the Integumentary System ................................................................................ 96
h1 h1 h1 h1 h1 h1
Chapter 24. Drugs Used to Treat Bacterial Infections .................................................................................. 101
h1 h1 h1 h1 h1 h1 h1
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ................................................. 105
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 26. Drugs Used to Treat Inflammatory Processes ........................................................................... 108
h1 h1 h1 h1 h1 h1 h1
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ............................................................................ 111
h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 28. Anemia ......................................................................................................................................... 113
h1 h1
Chapter h1 29. h1 Anxiety and Depression .............................................................................................................. 116
h1 h1
Chapter h1 30. h1 Attention Deficit-Hyperactivity Disorder ................................................................................... 120
h1 h1
Chapter h1 31. h1 Asthma and Allergy .................................................................................................................... 122
h1 h1
Chapter h1 32. h1 Chronic Obstructive Pulmonary Disease .................................................................................... 125
h1 h1 h1
Chapter h1 33. h1 Contraception ............................................................................................................................... 127
Chapter h1 34. h1 COVID-19: Acute and Chronic .................................................................................................. 130
h1 h1 h1
Chapter h1 35. h1 Dermatological Conditions .......................................................................................................... 134
h1
Chapter h1 36. h1 Diabetes Management ................................................................................................................. 138
h1
Chapter h1 37. h1 Gastroesophageal Reflux and Peptic Ulcer Disease.................................................................. 146
h1 h1 h1 h1 h1
Chapter h1 38. h1 Headaches ..................................................................................................................................... 149
Chapter h1 39. h1 Heart Failure ................................................................................................................................ 153
h1
Chapter h1 40. h1 HIV Disease and Acquired Immunodeficiency Syndrome ....................................................... 158
h1 h1 h1 h1 h1
Chapter 41. Menopausal Hormone Therapy................................................................................................... 161
h1 h1 h1 h1
,Chapter 42. Hyperlipidemia ............................................................................................................................. 164
h1 h1
Chapter 43. Hypertension................................................................................................................................. 169
h1 h1
Chapter 44. Hyperthyroidism and Hypothyroidism........................................................................................ 174
h1 h1 h1 h1
Chapter 45. Obesity ......................................................................................................................................... 177
h1 h1
Chapter 46. Pain Management: Acute and Chronic Pain ............................................................................. 181
h1 h1 h1 h1 h1 h1 h1
Chapter 47. Pneumonia .................................................................................................................................... 185
h1 h1
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................ 187
h1 h1 h1 h1 h1 h1
Chapter 49. Substance Use Disorders ............................................................................................................. 190
h1 h1 h1 h1
Chapter 50. Tuberculosis ................................................................................................................................. 195
h1 h1
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ... 197
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
Chapter 52. Urinary Tract Infections .............................................................................................................. 200
h1 h1 h1 h1
Chapter h1 53. h1 Women as Patients ...................................................................................................................... 203
h1 h1
Chapter h1 54. h1 Men as Patients ........................................................................................................................... 207
h1 h1
Chapter h1 55. h1 Pediatric Patients.......................................................................................................................... 209
h1
Chapter h1 57. h1 Geriatric Patients.......................................................................................................................... 213
h1
, Woo 1
Pharmacotherapeutics for APN Prescribers, h1 h1 h1 Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
MULTIPLE CHOICE h1
1. Nurse practitioner prescriptive authority is regulated by:
h1 h1 h1 h1 h1 h1
A. The National Council of State Boards of Nursing
h1 h1 h1 h1 h1 h1 h1
B. The U.S. Drug Enforcement Administration
h1 h1 h1 h1
C. The State Board of Nursing for each state
h1 h1 h1 h1 h1 h1 h1
D. The State Board of Pharmacy
h1 h1 h1 h1
ANS: h 1 C PTS: h 1 h 1 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
prescriber include:
h1 h1
A. Nurses know more about pharmacology than other prescribers because they take
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
it both in their basic nursing program and in their APRN program.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Nurses care for the patient from a holistic approach and include the
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
patient in decision-making regarding their care.
h1 h1 h1 h1 h1 h1
C. APRNs are less likely to prescribe narcotics and other controlled substances.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
D. APRNs are able to prescribe independently in all states, whereas a
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
physician’s assistant needs to have a physician supervising their practice.
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
ANS: h 1 B PTS: h 1 h 1 1
3. Clinical judgment in prescribing includes:
h1 h1 h1 h1
A. Factoring in the cost to the patient of the medication prescribed
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Always prescribing the newest medication available for the disease process
h1 h1 h1 h1 h1 h1 h1 h1 h1
C. Handing out drug samples to poor patients
h1 h1 h1 h1 h1 h1
D. Prescribing all generic medications to cut costs h1 h1 h1 h1 h1 h1
ANS: h 1 A PTS: h 1 h 1 1
4. The process for choosing an effective drug for a disorder includes:
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
A. Asking the patient what drug they think would work best for them
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
B. Consulting nationally recognized guidelines for disease management
h1 h1 h1 h1 h1 h1
C. Prescribing medications that are available as samples before writing a prescription
h1 h1 h1 h1 h1 h1 h1 h1 h1 h1
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
h1 h1 h1 h1 h1 h1 h1
ANS: h 1 B PTS: h 1 h 1 1
5. Nonintentional nonadherence of drug therapy may occur due to:
h1 h1 h1 h1 h1 h1 h1 h1
A. Belief that medication does not work
h1 h1 h1 h1 h1
B. Adverse drug reactions h1 h1
C. Chronic conditions that require daily therapy
h1 h1 h1 h1 h1
D. Forgetfulness or distraction h1 h1
ANS: h 1 D PTS: h 1 h 1 1
